Table 1.
Demographic and clinical characteristics of the total sample.
| Variables | Total sample (N = 41) |
|---|---|
| Mean (SD) | |
| Age | 48.5 (14.3) |
| BMI | 27.5 (5.6) |
| Episode duration (weeks) | 26.9 (29.0) |
| Number of depressive episodes | 6.1 (8.1) |
| Baseline results (before infusion) | |
| SHAPS | 9.6 (3.5) |
| IDS-30 total | 46.7 (13.1) |
| IDS item no. 18 | 1.2 (1.2) |
| Diagnosis | N (%) |
| MDD | 28 (68.3%) |
| BD | 13 (31.7%) |
| Sex | |
| Females | 26 (63.4%) |
| Males | 15 (36.6%) |
| Education | |
| Primary | 2 (4.9%) |
| Secondary | 4 (9.8%) |
| Vocational | 16 (39.0%) |
| Higher | 19 (46.3%) |
| Employment status | |
| Unemployed | 8 (19.5%) |
| Pension | 16 (39.0%) |
| Retirement | 7 (17.1%) |
| Employed | 9 (22.0%) |
| Study | 1 (2.4%) |
| Marital status | |
| Single | 11 (26.8%) |
| Informal relationship | 2 (4.9%) |
| Married | 20 (48.8%) |
| Divorced | 5 (12.2%) |
| Widowed | 3 (7.3%) |
| Concomitant meds | |
| TCA | MDD: 4 (14.3%), BD: 0 (0%) |
| SSRI | MDD: 16 (57.1%), BD: 4 (30.8%) |
| SNRI | MDD: 5 (17.9%), BD: 5 (38.5%) |
| Other | MDD: 11 (39.3%), BD: 3 (23.1%) |
| Antipsychotics | MDD: 8 (28.6%), BD: 8 (61.5%) |
| Mood stabilizers | MDD: 10 (35.7%), BD: 10 (76.9%) |
| Lithium | MDD: 0 (0%), BD: 3 (23.1%) |
| BDZ | MDD: 12 (42.9%), BD: 8 (61.5%) |
SHAPS, Snaith–Hamilton Pleasure Scale; IDS-SR 30, 30-Item Inventory for Depressive Symptomatology—Self Report; SD, standard deviation; BMI, body mass index; MDD, major depressive disorder; BD, Bipolar disorder; SSRI, selective serotonin reuptake inhibitors; SNRI, serotonin and noradrenaline reuptake inhibitors; AD, antidepressants; TCA, tricyclic antidepressants; BDZ, benzodiazepines.